Maze Therapeutics, Inc.
MAZENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for MAZE. That does not mean none is planned.
Get an email about MAZE's next catalysts
Track Maze Therapeutics (MAZE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Frequently asked questions
What is in Maze Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Maze Therapeutics, Inc.'s (MAZE) pipeline across Phase 2. Its lead program is MZE782 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Maze Therapeutics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Maze Therapeutics, Inc. (MAZE) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MAZE biotech catalysts?→
Add MAZE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Maze Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.